|
| 37902921 | Characterization of pulmonary arterial stiffness using cardiac MRI. | Int J Cardiovasc Imaging | 2024 |
| 36027975 | Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network Registry. | J Pediatr | 2023 |
| 37491551 | Extraction and Digitization of ECG Signals from Standard Clinical Portable Document Format Files for the Principal Component Analysis of T-wave Morphology. | Cardiovasc Eng Technol | 2023 |
| 37915400 | Kids Mod PAH trial: A multicenter trial comparing mono- versus duo-therapy for initial treatment of pediatric pulmonary hypertension. | Pulm Circ | 2023 |
| 37488167 | Myocardial strain-curve deformation patterns after Fontan operation. | Sci Rep | 2023 |
| 37517653 | Measurement of Physical Activity by Actigraphy in Infants and Young Children with Pulmonary Arterial Hypertension. | J Pediatr | 2023 |
| 37941938 | 4D-Flow MRI intracardiac flow analysis considering different subtypes of pulmonary hypertension. | Pulm Circ | 2023 |
| 35852579 | Abnormal flow conduction through pulmonary arteries is associated with right ventricular volume and function in patients with repaired tetralogy of Fallot: does flow quality affect afterload? | Eur Radiol | 2023 |
| 37152104 | Insulin-like growth factor binding Protein-4: A novel indicator of pulmonary arterial hypertension severity and survival. | Pulm Circ | 2023 |
| 37106091 | Computed tomographic parenchymal lung findings in premature infants with pulmonary vein stenosis. | Pediatr Radiol | 2023 |
| 37400886 | Ventricular global function index is associated with clinical outcomes in pediatric pulmonary hypertension. | J Cardiovasc Magn Reson | 2023 |
| 37357777 | Pulmonary Hypertension in Congenital Heart Disease: A Scientific Statement From the American Heart Association. | Circ Heart Fail | 2023 |
| 36723625 | Management of Complex Pulmonary Vein Stenosis at Altitude Combining Comprehensive Percutaneous Interventional Treatment with Sirolimus, Pulmonary Hypertension Medications and Intraluminal Imaging with Optical Coherence Tomography. | Pediatr Cardiol | 2023 |
| 36847876 | Letter to the Editor, regarding Li L, Zhu X, Chen X, Gao J, Ding C, et al. Advances in targeted therapy for pulmonary arterial hypertension in children. Eur J Pediatr. 2022 Dec 17. | Eur J Pediatr | 2023 |
| 36776484 | Computational platform for doctor-artificial intelligence cooperation in pulmonary arterial hypertension prognostication: a pilot study. | ERJ Open Res | 2023 |
| 36463937 | Hemodynamic Characterization of Neonates With Congenital Diaphragmatic Hernia-Associated Pulmonary Hypertension by Cardiac Catheterization. | J Pediatr | 2023 |
| 36562650 | High altitude pulmonary edema in children: A systematic review. | Pediatr Pulmonol | 2023 |
| 34181866 | Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, Combine. | Ann Am Thorac Soc | 2022 |
| 35384735 | High-Altitude Pulmonary Edema in Colorado Children: A Cross-Sectional Survey and Retrospective Review. | High Alt Med Biol | 2022 |
| 35769420 | <i>COL18A1</i> genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association study. | ERJ Open Res | 2022 |
| 35506100 | Hepatoma-derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival. | Pulm Circ | 2022 |
| 35689704 | Chest computed tomography findings of ground-glass nodules with enhancing central vessel/nodule in pediatric patients with BMPR2 mutations and plexogenic arteriopathy. | Pediatr Radiol | 2022 |
| 35514776 | Proteomics discovery of pulmonary hypertension biomarkers: Insulin-like growth factor binding proteins are associated with disease severity. | Pulm Circ | 2022 |
| 36540874 | Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association Registry. | Pulm Circ | 2022 |
| 36533232 | Novel use of riociguat in infants with severe pulmonary arterial hypertension unable to wean from inhaled nitric oxide. | Front Pediatr | 2022 |
| 36186721 | Riociguat in children with pulmonary arterial hypertension: The PATENT-CHILD study. | Pulm Circ | 2022 |
| 34921523 | Safety and tolerability of combination therapy with ambrisentan and tadalafil for the treatment of pulmonary arterial hypertension in children: Real-world experience. | Pediatr Pulmonol | 2022 |
| 35037988 | Technical Feasibility on the Use of Optical Coherence Tomography in the Evaluation of Pediatric Pulmonary Venous Stenosis. | Pediatr Cardiol | 2022 |
| 35037192 | Pulmonary Hypertension in the Population with Down Syndrome. | Cardiol Ther | 2022 |
| 34872760 | Monitoring and evaluation of the surgical Potts shunt physiology using 4-dimensional flow magnetic resonance imaging. | J Thorac Cardiovasc Surg | 2022 |
| 35229614 | Repolarization Dispersion Is Associated With Diastolic Electromechanical Discoordination in Children With Pulmonary Arterial Hypertension. | J Am Heart Assoc | 2022 |
| 34687693 | Biomarkers of Pulmonary Hypertension Are Altered in Children with Down Syndrome and Pulmonary Hypertension. | J Pediatr | 2022 |
| 32763037 | Pulmonary vein stenosis: Treatment and challenges. | J Thorac Cardiovasc Surg | 2021 |
| 33653609 | High-degree Norwood neoaortic tapering is associated with abnormal flow conduction and elevated flow-mediated energy loss. | J Thorac Cardiovasc Surg | 2021 |
| 33623667 | Practice patterns of pulmonary hypertension secondary to left heart disease among pediatric pulmonary hypertension providers. | Pulm Circ | 2021 |
| 33821682 | Short-Term Effects of Inhaled Nitric Oxide on Right Ventricular Flow Hemodynamics by 4-Dimensional-Flow Magnetic Resonance Imaging in Children With Pulmonary Arterial Hypertension. | J Am Heart Assoc | 2021 |
| 33609516 | ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical Worsening. | Chest | 2021 |
| 34905397 | An Acute Hyperoxia Test Predicts Survival in Children with Pulmonary Hypertension Living at High Altitude. | High Alt Med Biol | 2021 |
| 34583983 | Ventricular-vascular coupling is predictive of adverse clinical outcome in paediatric pulmonary arterial hypertension. | Open Heart | 2021 |
| 34622662 | Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension. | J Am Heart Assoc | 2021 |
| 34651041 | The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension. | ERJ Open Res | 2021 |
| 34222150 | Echocardiographic Changes and Long-Term Clinical Outcomes in Pediatric Patients With Pulmonary Arterial Hypertension Treated With Bosentan for 72 Weeks: A <i>Post-hoc</i> Analysis From the FUTURE 3 Study. | Front Pediatr | 2021 |
| 34158918 | Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry. | Pulm Circ | 2021 |
| 34078382 | Pulmonary arterial banding in mice may be a suitable model for studies on ventricular mechanics in pediatric pulmonary arterial hypertension. | J Cardiovasc Magn Reson | 2021 |
| 34234945 | Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double-blind placebo-controlled study. | Pulm Circ | 2021 |
| 34140292 | Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry. | Eur Respir J | 2021 |
| 34085841 | Metalloproteinases and their inhibitors are associated with pulmonary arterial stiffness and ventricular function in pediatric pulmonary hypertension. | Am J Physiol Heart Circ Physiol | 2021 |
| 34021434 | Abnormal pulmonary flow is associated with impaired right ventricular coupling in patients with COPD. | Int J Cardiovasc Imaging | 2021 |
| 32049444 | Pulmonary hypertension in children with Down syndrome. | Pediatr Pulmonol | 2021 |
| 33400972 | Longitudinal assessment of right atrial conduit fraction provides additional insight to predict adverse events in pediatric pulmonary hypertension. | Int J Cardiol | 2021 |